New ultrasound therapy okay for patients not suitable for TAVR, SAVR

Delhi: Non-Invasive Ultrasound Therapy (NIUT) holds promise for the treatment of cardio-valvular diseases such as aortic stenosis, according to a recent study presented at PCR e-Course 2020.

Aortic stenosis is one of the leading causes of cardiovascular death worldwide. The non-invasive real-time image-guided medical device that uses a cutting-edge ultrasound technology, known as Pulsed Cavitational Ultrasound Therapy (PCUT), has been developed by Cardiawave (France). 

This treatment is suitable for aortic stenosis patients who are either poor candidates for TAVR or SAVR or who have other reasons to avoid or prolong valve replacement, suggests a small, first-in-man trial.

The device allows physicians to deliver with a non-invasive medical device mechanical energy on a moving target with high precision, while at the same time preserving the tissue and organs through which the ultrasound passes. Unlike any existing technology, it is possible to target and treat, almost simultaneously, several anatomical zones spread over a large area without physically moving the medical device, which is placed on the patient's chest, over the beating heart. Treatment is monitored in real-time.